Pacific Heights Asset Management LLC Increases Holdings in Agilent Technologies, Inc. $A

Pacific Heights Asset Management LLC increased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 25.0% in the fourth quarter, Holdings Channel reports. The firm owned 150,000 shares of the medical research company’s stock after acquiring an additional 30,000 shares during the period. Pacific Heights Asset Management LLC’s holdings in Agilent Technologies were worth $20,410,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Bridgefront Capital LLC acquired a new stake in Agilent Technologies during the third quarter valued at approximately $1,323,000. Wellington Management Group LLP raised its stake in Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after buying an additional 433,342 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in Agilent Technologies by 3.8% during the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after buying an additional 22,498 shares in the last quarter. Lmcg Investments LLC raised its stake in Agilent Technologies by 13.6% during the third quarter. Lmcg Investments LLC now owns 82,905 shares of the medical research company’s stock valued at $10,641,000 after buying an additional 9,911 shares in the last quarter. Finally, Generation Investment Management LLP raised its stake in Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after buying an additional 582,093 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Barclays cut their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Morgan Stanley cut their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. UBS Group cut their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, Wells Fargo & Company cut their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Stock Down 0.0%

NYSE:A opened at $111.69 on Monday. The firm has a market capitalization of $31.56 billion, a PE ratio of 24.66, a price-to-earnings-growth ratio of 2.35 and a beta of 1.22. The stock has a 50 day moving average of $115.06 and a 200-day moving average of $130.57. Agilent Technologies, Inc. has a 52 week low of $107.07 and a 52 week high of $160.27. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.